5 July 2018
Our systematic review of women’s perceptions showed that women carefully review their perceived susceptibility to breast cancer when considering the adoption of this novel screening and prevention programme. Their decisions about participation are based on a cost-benefit analysis of adopting tailored screening, risk-reducing medication, lifestyle changes, and/or prophylactic surgery, whilst taking into account their own perceived competence, autonomy, relatedness to others, and personal preference.
To obtain further insights on acceptability, we performed a mixed-methods study with healthcare professionals from the Netherlands, Sweden, and the United Kingdom who identified five themes that could impact women’s decision-making: (1) Anxiety/worry, (2) Proactive approach, (3) Reassurance, (4) Lack of knowledge, and (5) Organisation of risk assessment and feedback. Dutch and British professionals specifically expressed concerns about the acceptability of a heterogeneous screening policy, suggesting women will question their risk feedback and assigned pathway of care. Swedish professionals emphasised the potential impact on family relations.
Our review of future organisational implications of introducing risk-based breast cancer screening and prevention shows that significant changes in policy and practice are warranted. Feasibility of implementation depends on how healthcare is funded and arranged, and potentially varies between countries. Pilot studies of risk assessment and prevention counselling in primary care settings have highlighted a need for extensive additional training on risk (communication) and prevention, the impact on workflow, and professionals' personal discomfort breaching the topic with women. Additionally, gaps in risk estimation, psychological, ethical and legal consequences will need to be addressed.
Publications
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Rainey L, van der Waal D, Wengström Y, Jervaeus A, Broeders MJM.
Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Rainey L, van der Waal D, Donnelly LS, Evans DG, Wengström Y, Broeders M.
Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Rainey L, van der Waal D, Jervaeus A, Wengström Y, Evans DG, Donnelly LS, Broeders MJM.
Linda Rainey, Mireille Broeders, and Daniëlle van der Waal are all members of theme Women’s cancers.
Linda Rainey, Mireille Broeders, Daniëlle van der Waal, and colleagues published three papers last month on the future implementation of risk-based breast cancer screening and prevention.
Our systematic review of women’s perceptions showed that women carefully review their perceived susceptibility to breast cancer when considering the adoption of this novel screening and prevention programme. Their decisions about participation are based on a cost-benefit analysis of adopting tailored screening, risk-reducing medication, lifestyle changes, and/or prophylactic surgery, whilst taking into account their own perceived competence, autonomy, relatedness to others, and personal preference.
To obtain further insights on acceptability, we performed a mixed-methods study with healthcare professionals from the Netherlands, Sweden, and the United Kingdom who identified five themes that could impact women’s decision-making: (1) Anxiety/worry, (2) Proactive approach, (3) Reassurance, (4) Lack of knowledge, and (5) Organisation of risk assessment and feedback. Dutch and British professionals specifically expressed concerns about the acceptability of a heterogeneous screening policy, suggesting women will question their risk feedback and assigned pathway of care. Swedish professionals emphasised the potential impact on family relations.
Our review of future organisational implications of introducing risk-based breast cancer screening and prevention shows that significant changes in policy and practice are warranted. Feasibility of implementation depends on how healthcare is funded and arranged, and potentially varies between countries. Pilot studies of risk assessment and prevention counselling in primary care settings have highlighted a need for extensive additional training on risk (communication) and prevention, the impact on workflow, and professionals' personal discomfort breaching the topic with women. Additionally, gaps in risk estimation, psychological, ethical and legal consequences will need to be addressed.
Publications
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Rainey L, van der Waal D, Wengström Y, Jervaeus A, Broeders MJM.
Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Rainey L, van der Waal D, Donnelly LS, Evans DG, Wengström Y, Broeders M.
Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Rainey L, van der Waal D, Jervaeus A, Wengström Y, Evans DG, Donnelly LS, Broeders MJM.
Linda Rainey, Mireille Broeders, and Daniëlle van der Waal are all members of theme Women’s cancers.
Related news items

Mireille Broeders appointed member of the Dutch Health Council
16 November 2021 Mireille Broeders, professor of Personalized Cancer Screening, has been appointed as a member of the permanent Committee on Population Screening of the Dutch Health Council (Gezondheidsraad). read more
Mireille Broeders appointed full Professor of Personalized Cancer Screening
18 June 2020 Mireille Broeders of the Department for Health Evidence has been appointed full professor of Personalized Cancer Screening. This appointment became effective on 1 May 2020. read more
Awarded KWF grants for Radboudumc researchers
18 December 2019 KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work. read more
European Commission Initiative on Breast Cancer (ECIBC) Guidelines
13 August 2019 In Annals of internal medicine Mireille Broeders and colleagues from the ECIBC Guidelines Development Group described the methods used to develop person-centered evidence-based recommendations for screening and diagnosis of breast cancer. read more
Bart Kiemeney finishes 1st in the Tour and raises thousands of euros
30 July 2019 With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success. read more